Impacts of the Callipyge mutation on ovine plasma metabolites and muscle fibre type

PLoS One. 2014 Jun 17;9(6):e99726. doi: 10.1371/journal.pone.0099726. eCollection 2014.

Abstract

The ovine Callipyge mutation causes postnatal muscle hypertrophy localized to the pelvic limbs and torso, as well as body leanness. The mechanism underpinning enhanced muscle mass is unclear, as is the systemic impact of the mutation. Using muscle fibre typing immunohistochemistry, we confirmed muscle specific effects and demonstrated that affected muscles had greater prevalence and hypertrophy of type 2X fast twitch glycolytic fibres and decreased representation of types 1, 2C, 2A and/or 2AX fibres. To investigate potential systemic effects of the mutation, proton NMR spectra of plasma taken from lambs at 8 and 12 weeks of age were measured. Multivariate statistical analysis of plasma metabolite profiles demonstrated effects of development and genotype but not gender. Plasma from Callipyge lambs at 12 weeks of age, but not 8 weeks, was characterized by a metabolic profile consistent with contributions from the affected hypertrophic fast twitch glycolytic muscle fibres. Microarray analysis of the perirenal adipose tissue depot did not reveal a transcriptional effect of the mutation in this tissue. We conclude that there is an indirect systemic effect of the Callipyge mutation in skeletal muscle in the form of changes of blood metabolites, which may contribute to secondary phenotypes such as body leanness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / metabolism
  • Adiposity / genetics*
  • Animals
  • Biomarkers / blood
  • DNA, Intergenic
  • Genetic Association Studies
  • Hypertrophy / blood
  • Hypertrophy / genetics
  • Hypertrophy / veterinary
  • Laminin / metabolism
  • Metabolic Networks and Pathways
  • Metabolome
  • Multivariate Analysis
  • Muscle Fibers, Fast-Twitch / metabolism
  • Muscle Fibers, Fast-Twitch / pathology
  • Muscle, Skeletal / pathology
  • Muscular Diseases / blood
  • Muscular Diseases / genetics
  • Muscular Diseases / veterinary*
  • Mutation
  • Myosin Heavy Chains / metabolism
  • Phenotype
  • Sheep / genetics*
  • Sheep Diseases
  • Sheep, Domestic / genetics*
  • Transcriptome

Substances

  • Biomarkers
  • DNA, Intergenic
  • Laminin
  • Myosin Heavy Chains

Grants and funding

The authors acknowledge financial support provided by the Queensland State Government to the Queensland NMR Network facilities, as well as project and fellowship support (to Juan Li) from the CSIRO Office of the Chief Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.